View Older Stories View More Recent Stories
-
UnitedHealth Group (UNH), Humana (HUM), Others Climb
-
Raymond James on Humana (HUM): 'Medicaid Fears Didn't Surface, and Core Guide Raise Better Than It Appears'
-
Humana (HUM) Tops Q2 EPS by 40c; raises guidance
-
Humana to eliminate one-third of prior authorizations by 2026
-
UBS Reiterates Neutral Rating on Humana (HUM)
-
Guggenheim Reiterates Buy Rating on Humana (HUM)
-
Morgan Stanley Reiterates Equalweight Rating on Humana (HUM)
-
Leerink Partners Reiterates Market Perform Rating on Humana (HUM)
-
Raymond James Reiterates Outperform Rating on Humana (HUM)
-
Mizuho weighs in on Humana (HUM) after it lost MA stars lawsuit
-
Barclays Comments on Humana (HUM) Dismissal
-
Texas Judge dismisses Humana (HUM) challenge to Medicare quality bonus payment for 2026 - court document
-
Humana stock falls after losing Medicare bonus payment lawsuit
-
Humana (HUM) Loses Medicare Bonus Payment Lawsuit - Bloomberg
-
Humana (HUM) Launches Medicaid Plan in Virginia
-
Centene (CNC) PT Lowered to $52 at BofA Securities
-
Humana (HUM) Healthcare stocks on watch after Centene withdraws guidance
-
Humana (HUM) PT Raised to $340 at Raymond James
-
Humana (HUM) expands SBT with SBTi initiative
-
Health Insurers To Promise Changes To Preapproval Process - WSJ
-
Bernstein on Humana (HUM): 'We Are Positive on the Sector Turnaround Opportunities'
-
TD Cowen Reiterates Hold Rating on Humana (HUM)
-
RBC Capital on Humana (HUM): 'Multiple Levers To Drive Strong EPS Growth Expected By 2028'
-
Humana (HUM) PT Lowered to $280 at Truist Securities
-
UBS Reiterates Neutral Rating on Humana (HUM)
-
UBS Reiterates Neutral Rating on Humana (HUM)
-
Mizuho Reiterates Outperform Rating on Humana (HUM)
-
Cantor Fitzgerald Reiterates Neutral Rating on Humana (HUM)
-
Humana (HUM) Planning Business Assuming They Lose Stars Lawsuit: CEO - Bloomberg
-
Bernstein's Expectations for Humana (HUM) Ahead of Investor Day
-
Humana (HUM) PT Lowered to $244 at Jefferies
-
Medicare Surfaces as Target for Cuts to Pay for Trump Tax Bill'- Bloomberg
-
Cantor Fitzgerald Reiterates Neutral Rating on Humana (HUM)
-
Bernstein Reiterates Outperform Rating on Humana (HUM)
-
Cantor Fitzgerald says CMS' new audit strategy has logistical challenges
-
Keybanc: 'CMS Expanding RADV Audits, MA Can't Catch a Break'
-
Humana (HUM) call put ratio 1 call to 2 puts on 11K contracts
-
After-hours movers: Snowflake, Urban Outfitters, CVS Health
-
UnitedHealth (UNH), Others Lower as CMS Will Expand Audits Of Medicare Advantage Plans
-
TD Cowen on UnitedHealth Group (UNH): 'We see elevated negative headline risk in the near term'
-
Humana (HUM) May 215 puts active as share price down 6.5%
-
Bernstein: 'We See the Reaction to PBM Stocks as Off Target'
-
TD Cowen on UnitedHealth Group (UNH): 'today's comments will call into question FY guidance for every MCO'
-
United States Files False Claims Act Complaint Against Three National Health Insurance Companies and Three Brokers
-
Raymond James Upgrades Humana (HUM) to Outperform
-
Humana (HUM) Tops Q1 EPS by 151c; offers guidance
-
Humana (HUM) call put ratio 1 call to 1.4 puts into quarter results
-
Humana (HUM) call put ratio 1.1 calls to 1 put as share price down 7.5%
-
Options with increasing option implied volatility: HTZ TRVI QURE NEXT HUM CVS ELV UNH CNC
-
Guggenheim Starts Humana (HUM) at Buy
